Page 157 - CW E-Magazine (19-3-2024)

Meetings & Conferences News from Abroad

12-14 | Ho Chi Minh City, Vietnam September 2024 : +91-84461 76554 DIVESTMENT
Coatings Expo Vietnam 2024 – 9-11 | Houston, Texas, US  : Fatimakhan@mediafusionme.com
The 9th International Exhibition on World Chemical Forum 2024 : Ifpuexpo.com Evonik sells superabsorbents business to ICIG
Coatings and Printing Inks Industry Chemical Market Analytics by OPIS
in Vietnam  : +1-301-966 7270 19-21 | Shanghai, China Germany’s Evonik said it is selling
Minh Vi Exhibitions and Advertisement  : Support@chemicalmarketanalytics.com ICIF China 2024 21st China Inter- its superabsorbents business to the
Services Co. Ltd. (VEAS) : Chemicalmarketanalytics.com/world- International Chemical Investors Group
(ICIG) for an enterprise value in the
 : +84-28 3848 8561 chemical-forum/ national Chemical Industry Fair “low triple-digit million euro range”.
 : Info@veas.com.vn CCPIT Sub-Council of Chemical The agreement also includes the
: Coatings-vietnam.com 10-12 | Dubai, UAE Industry assumption of pension obligations by
UTECH Middle East Foam & Poly- : Mao Menglin ICIG.
19-20 | Messe Düsseldorf, Germany urethane Expo  : +86-10-6428 5845
ICIG is a privately-owned Germany-
Chemspec Europe 2024 Media Fusion & Crain Communications  : Maoml@ccpitchem.org.cn based industrial group with sales in
RX Global : Ms. Fatima Khan : Icif.cn excess of €4.6-bn and focussed on fi ve
: Gloria Vezzoli main platforms of fi ne chemicals (Weyl-
 : +44-(0)-1727 814 543 Chem brand), care chemicals (Catexel
 : Chemspeceurope@rxglobal.com brand), chlorovinyls (Vynova brand),
compounds (Benvic brand), hydro-
: Chemspeceurope.com carbons & solvents (HCS brand), and
INDIA Enterprises, which comprises several
24-27 | Marseille, France specifi ed companies. In April 2023, ICIG had already of €892-mn in 2023, with adjusted
32nd European Biomass Conference acquired the Luelsdorf site and associated EBITDA in the mid double-digit million
ICIG has extensive expertise in businesses in Wesseling from Evonik euro range.
and Exhibition – EUBCE 2024 the development of sites and business and announced extensive investments
ETA-Florence Renewable Energies units that are no longer part of the core there. Like the superabsorbent busi- ICIG is taking over the entire division
 : +39-055 5002174 R R business at corporate groups. ness, the site previously belonged to with around 1,000 employees and super-
 : Eubce@etaflorence.it, biomass. the Performance Materials Division. absorber production facilities in Krefeld
“In terms of its profi le, the super-
Its third part are chemicals from the C4 and Rheinmuenster, Germany, as well as
conference@etaflorence.it Hall 1 Hall 2 Hall 3 absorbents business no longer fi ts our chain, a business that is also up for sale. two locations in the US in Greensboro,
: Eubce.com character as a speciality chemicals North Carolina, and Garyville, Louisiana.
company. Our company is thus taking Superabsorbents are powdered poly- The business also includes plants in
Filling Fast !!
27-28 | Singapore Sold Out !!! Sold Out !!! Few Stands Left the second step in the divestment of our mers used as absorbent materials in Marl, Germany, for production of acrylic
27th ICIS and Tecnon OrbiChem Performance Materials Division,” said diapers and other hygiene products. acid, the most important raw material for
World Chlor-Alkali Conference Mr. Christian Kullmann, CEO, Evonik. The business to be sold generated sales superabsorbents.
: Nicol Lange
 : +44-(0)-20 7911 1393 C2 Pharma to launch a new ophthalmic API
 : Nicol.lange@icis.com.
C2 Pharma, the Ireland-based pharma used especially in ophthalmology and DMF) by August 2024, and a Certi-
August 2024 APRIL 2024 firm, has announced the upcoming otolaryngology for short term medical fi cate of Acceptance of Drugs and Food
launch of their new API, oxybuprocaine procedures.
(CADIFA) in Q4 of 2024,” the company
27-29 | Seoul, South Korea 24 25 HALL 1, 2 & 3 | BEC | MUMBAI hydrochloride. informed.
CPHI Korea 2024 “We are completing the validation
The company said the API, to be process, by April 2024, and upon com-
“We will further be expanding our
Informa Markets Korea Corporation made by its Hyderabad-based manu- pletion, GMP samples will be available range of high-quality ophthalmic-APIs
: Ms. Helena Kim facturing partner, Laurus Labs, will to our customers worldwide for evalu- throughout 2024, with our next release
 : +82-2-6715-5422 extend its range of ophthalmic APIs. ation and testing. We expect to submit being Naphazoline Hydrochloride,”
 : Helena.kim@informa.com Oxybuprocaine (also known as Benoxi- a Certifi cate of Suitability (CEP) by revealed Mr. Andrew Badrot, CEO of
: Cphi.com/korea/en/home.html nate), is a local topical anaesthetic May 2024, a US-Drug Master File (US- C2 Pharma.

156 Chemical Weekly March 19, 2024 Chemical Weekly March 19, 2024 157

Contents Index to Advertisers Index to Products Advertised